نتائج البحث 1561-1570 من 9671 لعملية البحث عن prostate cancer
Rochester, Minn. The purpose of this study is to, in tissue, discover and validate DNA methylation markers (MDMs) for detection of invasive urothelial carcinoma ...
The purpose of this trial is to compare denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation. A germline mutation is ...
Mayo Clinic doctors and scientists are working together to find new ways to diagnose and treat brain tumors, including glioblastoma. Brain tumor research is ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
Nabil Wasif, M.D.. General Surgeon. Phoenix, AZ. مناطق التركيز: Neuroendocrine tumor, Pancreatic cancer, Stomach cancer, Pancreatic neuroendocrine tumor, ...
Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. ... This trial will also study the outcomes of patients with mixed ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
Michael L. Kendrick, M.D.. Surgical Oncologist; Hepatobiliary and Pancreas Surgeon. Rochester, MN. مناطق التركيز: Cancer treatment, Minimally invasive surgery, ...
Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of-care primary surgical ...
... cancer (HGSOC), including cancers of ovarian, fallopian tube or primary ... Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.